D
Alpha Tau Medical Ltd. DRTS
$7.33 $0.344.86% NASDAQ
Recommendation
Prev Close
$6.99
Volume
368,576
Avg Vol (90D)
191,711
Market Cap
$596.00M
Dividend & Yield
--
52-Week Range
$2.30 - $7.89
P/E (TTM)
--
EPS (TTM)
-$0.36
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event
1/23/2026 - ACCESS Newswire
Alpha Tau Medical: Pancreatic, GBM, And Other Updates; Set Up For A Strong, Catalyst-Rich 2026
1/23/2026 - Seeking Alpha - Long Ideas
Alpha Tau Medical: Pancreatic, GBM, And Other Updates; Set Up For A Strong, Catalyst-Rich 2026
1/23/2026 - Seeking Alpha - Israel Stocks
Alpha Tau Medical: Pancreatic, GBM, And Other Updates; Set Up For A Strong, Catalyst-Rich 2026
1/23/2026 - SeekingAlpha
Zacks Research Downgrades Alpha Tau Medical (NASDAQ:DRTS) to Strong Sell
1/21/2026 - MarketBeat
New Strong Sell Stocks for January 20th
1/20/2026 - Zacks Investment Research
Alpha Tau Medical Ltd. (NASDAQ:DRTS) Short Interest Up 29.2% in December
1/19/2026 - Ticker Report
Alpha Tau Medical Ltd. (NASDAQ:DRTS) Short Interest Up 29.2% in December
1/18/2026 - MarketBeat
Alpha Tau Medical (DRTS, $7.12) RSI Indicator left the overbought zone on January 16, 2026
1/17/2026 - Tickeron - Stocks
Alpha Tau Medical (NASDAQ:DRTS) Trading Down 6.2% - Should You Sell?
1/16/2026 - Ticker Report
Alpha Tau Medical (NASDAQ:DRTS) Shares Down 6.2% - Here's Why
1/16/2026 - MarketBeat
Alpha Tau Medical (NASDAQ:DRTS) Shares Gap Up - What's Next?
1/14/2026 - MarketBeat
Alpha Tau Medical (NASDAQ:DRTS) Shares Gap Up - What's Next?
1/14/2026 - Ticker Report
Alpha Tau Medical (DRTS, $6.56) RSI Indicator left the overbought zone on January 13, 2026
1/14/2026 - Tickeron - Stocks
Alpha Tau Medical (NASDAQ:DRTS) Hits New 52-Week High - Here's Why
1/13/2026 - MarketBeat
Alpha Tau Medical (NASDAQ:DRTS) Sees Large Volume Increase - What's Next?
1/8/2026 - Ticker Report
Alpha Tau Medical (NASDAQ:DRTS) Sees Large Volume Increase - What's Next?
1/8/2026 - MarketBeat
Alpha Tau Medical (NASDAQ:DRTS) Sets New 1-Year High - Here's Why
1/7/2026 - MarketBeat
Alpha Tau Medical (DRTS, $5.84) RSI Indicator left the overbought zone on January 06, 2026
1/7/2026 - Tickeron - Stocks
Alpha Tau Medical (DRTS, $5.84) Moving Average Convergence Divergence (MACD) Histogram turned positive on January 6, 2026
1/7/2026 - Tickeron - Stocks
Alpha Tau Medical (DRTS, $5.84) price may drop as it broke higher Bollinger Band on Jan 06, 2026
1/7/2026 - Tickeron - Stocks
Alpha Tau Medical Unveils Strong Pancreatic Cancer Alpha DaRT Data Ahead of ASCO GI 2026
1/6/2026 - TipRanks Financial Blog
Alpha Tau Reports New Positive Results in Two Upcoming Presentations at ASCO GI 2026 Symposium Showcasing Immune-Preservation and High Disease Control in Montreal Pancreatic Cancer Alpha DaRT Study
1/6/2026 - Globe Newswire
Alpha Tau Submits First Pre-Market Approval Module to the FDA for Alpha DaRT for the Treatment of Recurrent Cutaneous Squamous Cell Carcinoma (cSCC)
1/5/2026 - Globe Newswire
Short Interest in Alpha Tau Medical Ltd. (NASDAQ:DRTS) Expands By 58.8%
12/29/2025 - Ticker Report
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
$110.95M
Total Debt (Q)
$13.31M
Total Liabilities (Q)
$24.33M
Book Value Per Share (Q)
$1.02
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Monday, August 11, 2025
Period Date
Monday, June 30, 2025
Next Filing
(est)
Price History
Loading...
Beta
1.06
7-Day Total Return
-2.27%
30-Day Total Return
44.86%
60-Day Total Return
74.52%
90-Day Total Return
89.89%
Year to Date Total Return
51.76%
1-Year Total Return
81.89%
2-Year Total Return
138.76%
3-Year Total Return
70.47%
5-Year Total Return
--
52-week Low
Apr 04, 2025 - $2.30
52-week High
Jan 14, 2026 - $7.89
Valuation
Market Cap
$596.00M - Small Cap
Enterprise Value
$537.29M
Price/Sales (TTM)
--
Price/Book (Q)
6.86
Dividends and Shares
Shares Outstanding
80.45M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.alphatau.com
Phone Number
972 3 577 4115
Address
Kiryat HaMada St. 5
Jerusalem, 9777605
Country
Israel
Year Founded
--
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for... more
NASDAQ 01/26/2026 4:00PM Eastern Quotes delayed